Novalis Biotech

DAYLI Partners

Seoul-based Korean VC specializing in bio-healthcare and fintech, managing 47 funds with ~₩685B cumulative AUM across 123 portfolio companies.

Seed Series A BioTech HealthTech

Eisai Innovation Inc.

Corporate venture arm of Eisai investing ~$5M per deal in neurology, oncology, diagnostics, and digital health globally. Founded 2019; targets early-stage biotech and digital health startups.

Seed Series A BioTech HealthTech

Lilly Asia Ventures (LAV Fund)

Biomedical VC originating from Eli Lilly in 2008, now independent; invests in biopharmaceuticals, therapeutics, medical devices, and diagnostics across Asia and the US.

Seed Series A BioTech MedTech

Kaiser Permanente Ventures

Corporate VC arm of Kaiser Permanente investing in healthcare IT, digital health, medical devices, diagnostics, and precision medicine companies across the US.

Series A Series B HealthTech MedTech

Modi Ventures

Houston-based early-stage VC investing in funds and founders at the intersection of AI and biology.

Pre-Seed Seed BioTech HealthTech

Sonder Capital

Early-stage healthcare VC focused on medical device, diagnostic, and healthtech companies building transformational technologies that improve patient outcomes and create new standards of care. Acts as foundational investors providing hands-on strategic guidance from inception.

Pre-Seed Seed MedTech HealthTech

YZR Capital

Munich-based VC backing European HealthTech founders from pre-seed to Series B with hands-on operational support

Pre-Seed Seed HealthTech MedTech

Beiersdorf Venture Capital

Corporate VC arm of Beiersdorf investing in startups at the intersection of skin care, life sciences, AI, and sustainability

Seed Series A BioTech ClimateTech

CRB Health Tech

Spain-based VC managing three funds focused on biotech, medical devices, and digital health, investing from seed to Series A across Europe.

Seed Series A HealthTech BioTech